Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Squamous Cell Carcinoma of Head and Neck 7Rectal Neoplasms 7Oropharyngeal Neoplasms 7Head and Neck Neoplasms 6Carcinoma, Non-Small-Cell Lung 5Pancreatic Neoplasms 3Lung Neoplasms 3Hypopharyngeal Neoplasms 3Glioblastoma 3Esophageal Neoplasms 3Uterine Cervical Neoplasms 2Stomach Neoplasms 2Radiation Injuries 2Pathologic Complete Response 2Nasopharyngeal Carcinoma 2Mouth Neoplasms 2Laryngeal Neoplasms 2Vaginal Neoplasms 1Uterine Cervical Dysplasia 1Urinary Bladder Neoplasms 1Tobacco Use Disorder 1Thymoma 1Smoking Cessation 1Smoking 1Small Cell Lung Carcinoma 1Sinonasal undifferentiated carcinoma 1Sinonasal Squamous Cell Carcinoma 1Resectable Esophageal Cancer 1Rectal Malignant Neoplasms 1Postoperative Complications 1

Interventions

Cisplatin 26Paclitaxel 21pembrolizumab 15Radiotherapy 13Carboplatin 13tislelizumab 12Fluorouracil 12Drug Therapy 11Irinotecan 9toripalimab 8Esophagectomy 8Oxaliplatin 6Nivolumab 6Capecitabine 6Neoadjuvant Therapy 5Leucovorin 5Docetaxel 5lenvatinib 4camrelizumab 4Taxes 4Radiation 4Levoleucovorin 4Immune Checkpoint Inhibitors 4Albumin-Bound Paclitaxel 4130-nm albumin-bound paclitaxel 4spartalizumab 3sintilimab 3apatinib 3Itraconazole 3Injections 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Esophageal Squamous Cell Carcinoma × Chemoradiotherapy × 1 year × Clear all
NCT06452602 2026-02-27

Induction Immunochemotherapy Followed by Concurrent Chemoradiotherapy in Patients With ESCC.

Tianjin Medical University Cancer Institute and Hospital

Phase 2 Recruiting
60 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡